Details for New Drug Application (NDA): 016322
✉ Email this page to a colleague
NDA 016322 describes VALISONE, which is a drug marketed by Schering and is included in three NDAs. Additional details are available on the VALISONE profile page.
The generic ingredient in VALISONE is betamethasone valerate. There is one drug master file entry for this compound. Twelve suppliers are listed for this compound. Additional details are available on the betamethasone valerate profile page.
The generic ingredient in VALISONE is betamethasone valerate. There is one drug master file entry for this compound. Twelve suppliers are listed for this compound. Additional details are available on the betamethasone valerate profile page.
Summary for 016322
| Tradename: | VALISONE |
| Applicant: | Schering |
| Ingredient: | betamethasone valerate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 016322
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CREAM;TOPICAL | Strength | EQ 0.1% BASE | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CREAM;TOPICAL | Strength | EQ 0.01% BASE | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
